Sg3 Management, LLC Viking Therapeutics, Inc. Call Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$5.19 - $6.73 $259,500 - $336,500	-50,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.74 - $9.67 $287,000 - $483,500	50,000 New	50,000 $316,000
Q4 2018 Feb 12, 2019	SELL	$7.16 - $16.21 $17,900 - $40,525	-2,500 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.7 - $19.65 $24,250 - $49,125	2,500 New	2,500 $44,000

473

66.2M

5.72M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.03B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.